Search - tctmd.com

Displaying 341 - 360 of 440

Sort: Relevancy | Date

News Daily News

Statins Reduce Late Restenosis After SES Implantation

Jason Kahn

March 05, 2012

News Daily News

Meta-Analysis: Mixed Results Seen with First-Gen DES in STEMI Patients

March 05, 2012

News Daily News

Meta Análisis: Resultados Contradictorios con los SLF de 1ª Generación en Pacientes STEMI

March 05, 2012

News Daily News

Las Estatinas Reducen la Re-estenosis Tardía tras el Implante de un SLS

Jason Kahn

March 05, 2012

News Daily News

El Bloqueador de la Angiotensina Preserva la Función Endotelial Mejor que el Antagonista del Calcio

Jason Kahn

March 05, 2012

News Daily News

Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist

Jason Kahn

March 05, 2012

Presentation

Impact of Statin Therapy on Late TLR After Sirolimus-Eluting Stent (SES) Implantation

Presenter: 202206|M Natsuaki

March 04, 2012

News Daily News

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Yael L. Maxwell

February 15, 2012

News Daily News

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

January 24, 2012

Presentation

Very Late Stent Thrombosis and Late TLR After Sirolimus-Eluting Stent Implantation

Presenter: Takeshi Kimura

January 08, 2012

Presentation

Trombosis del Stent muy Tardía y RLD Tardía tras Implantación del Stent Liberador de Sirolimus

Presenter: Takeshi Kimura

January 08, 2012

News Daily News

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Jason Kahn

January 08, 2012

Presentation TCT 2012

Three Year Outcomes Of Chronic Total Occlusion Treatment With Biolimus Eluting Biodegradable Polymer Stent Versus Sirolimus Eluting Permanent Polymer Stent In the LEADERS...

Presenter: Joanna J. Wykrzykowska, Patrick Serruys, Ton de Vries, Gerrit-Anne Van Es, Pawel Buszman, Axel Linke, Thomas Ischinger, Volker Klauss, Roberto Corti, Franz Eberli, William Wijns, Marie-Claude Morice, Robert Jan van Geuns, Peter Juni, Stephan Windecker, Carlo DiMario

January 03, 2012

Presentation TCT 2012

Statin Therapy Reduces Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

Presenter: Masahiro Natsuaki, Takeshi Morimoto, Yutaka Furukawa, Satoshi Shizuta, Toru Kita, Takeshi Kimura

January 03, 2012

Presentation TCT 2012

Short-term effects of sirolimus eluting fully bioabsorbable polymeric coronary stents in a porcine model

Presenter: Li Shen, Qibing Wang, Yizhe Wu, Jian Xie, Junbo Ge

January 03, 2012

Presentation TCT 2012

Outcomes After Revascularization with Everolimus- and Sirolimus Eluting Stents In Patients with Acute Coronary Syndromes. A Substudy of the SORT OUT IV Trial.

Presenter: Lisbeth Antonsen, Per Thayssen, Henrik Steen Hansen, Michael Maeng, Hans-Henrik Tilsted, Evald Hoej Christiansen, Knud Noerregaard Hansen, Hans Erik Boetker, Jan Ravkilde, Lars Krusell, Morten Madsen, Henrik Toft Soerensen, Leif Thuesen, Jens Flensted Lassen, Lisette Okkels Jensen

January 03, 2012

Presentation TCT 2012

NOYA I: A Prospective Randomized Trial of NOYA Sirolimus-Eluting Stent with Biodegradable Coating Compared to FIREBIRD 2 Sirolimus-Eluting Stent with Durable Coating in...

Presenter: Kefei Dou, Bo Xu, Yuejin Yang, Shuzheng Lu, Lefeng Wang, Haichang Wang, Zhanquan Li, Lei Wang, Guoying Zhu, Wei Li, Run-Lin Gao

January 03, 2012

Presentation TCT 2012

No Difference In Long-term Major Adverse Cardiac Event Rates Between Paclitaxel-eluting and Sirolimus-eluting Stents.

Presenter: James P. Howard, Zia Buckhoree, Dan A. Jones, Sean M. Gallagher, Krishnaraj S. Rathod, Ajay K. Jain, Charles Knight, Anthony Mathur, Andrew Wragg

January 03, 2012

Presentation TCT 2012

Neointimal Hyperplasia and Peristent Vascular Remodeling after Implantation of Everolimus-eluting Stent versus Sirolimus-eluting Stent. Intravascular Ultrasound Results from...

Presenter: Young-Guk Ko, Dong-Ho Shin, Jung-Sun Kim, Byeong-Keuk Kim, Donghoon Choi, Myeong-Ki Hong, Hyeon-Cheol Gwon, Taehoon Ahn, In-Ho Chae, Jung-Han Yoon, Hyo-Soo Kim, Yangsoo Jang

January 03, 2012

Presentation TCT 2012

Long-term follow up of sirolimus-eluting stent(SES) implanted in coronary bifurcation lesion: Insight from OCT observations

Presenter: Hirotoshi Hariki, Junya Shite, Toshiro Shinke, Hiromasa Ootake, Masayuki Nakagawa, Ryouji Nagoshi, Takumi Inoue, Tsuyoshi Oosue, Amane Kozuki, Masamichi Iwasaki, Yu Taniguchi, Hiroto Kinutani, Akihide Konishi, Ryo Nishio, Noritoshi Hiranuma, Ken-ichi Hirata

January 03, 2012

Advertisement

Statins Reduce Late Restenosis After SES Implantation

Meta-Analysis: Mixed Results Seen with First-Gen DES in STEMI Patients

Meta Análisis: Resultados Contradictorios con los SLF de 1ª Generación en Pacientes STEMI

Las Estatinas Reducen la Re-estenosis Tardía tras el Implante de un SLS

El Bloqueador de la Angiotensina Preserva la Función Endotelial Mejor que el Antagonista del Calcio

Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist

Impact of Statin Therapy on Late TLR After Sirolimus-Eluting Stent (SES) Implantation

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

Very Late Stent Thrombosis and Late TLR After Sirolimus-Eluting Stent Implantation

Trombosis del Stent muy Tardía y RLD Tardía tras Implantación del Stent Liberador de Sirolimus

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Three Year Outcomes Of Chronic Total Occlusion Treatment With Biolimus Eluting Biodegradable Polymer Stent Versus Sirolimus Eluting Permanent Polymer Stent In the LEADERS...

Statin Therapy Reduces Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

Short-term effects of sirolimus eluting fully bioabsorbable polymeric coronary stents in a porcine model

Outcomes After Revascularization with Everolimus- and Sirolimus Eluting Stents In Patients with Acute Coronary Syndromes. A Substudy of the SORT OUT IV Trial.

NOYA I: A Prospective Randomized Trial of NOYA Sirolimus-Eluting Stent with Biodegradable Coating Compared to FIREBIRD 2 Sirolimus-Eluting Stent with Durable Coating in...

No Difference In Long-term Major Adverse Cardiac Event Rates Between Paclitaxel-eluting and Sirolimus-eluting Stents.

Neointimal Hyperplasia and Peristent Vascular Remodeling after Implantation of Everolimus-eluting Stent versus Sirolimus-eluting Stent. Intravascular Ultrasound Results from...

Long-term follow up of sirolimus-eluting stent(SES) implanted in coronary bifurcation lesion: Insight from OCT observations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content